Have Private Insurance Companies Updated Their Payment Policies for Molecular Testing Recently
Molecular testing has become an essential tool in diagnosing and treating various diseases, from cancer to infectious diseases. As a result, the demand for these tests has increased significantly in recent years. However, one of the challenges facing healthcare providers and patients is navigating the complex landscape of payment policies set by private insurance companies….